Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Tipo de estudo
Intervalo de ano de publicação
1.
J Cutan Aesthet Surg ; 9(3): 183-187, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27761089

RESUMO

BACKGROUND: Epidermal naevi are benign hamartomatous growths of the skin which are generally asymptomatic with a benign course but are cosmetically disagreeable. Topical treatments such as steroids, calcipotriol, 5 fluorouracil, podophyllin, retinoids and cryotherapy are ineffective and surgical excision results in scar formation. Therapy is often challenging. AIM OF THE STUDY: To study the response of carbon dioxide (CO2) laser in the management of epidermal naevi. SUBJECTS AND METHODS: We conducted a study of CO2 laser treatment on 15 patients of epidermal naevi, eight with verrucous epidermal naevi and seven with sebaceous naevi. A thorough history and examination was done to rule out any epidermal naevus syndrome. The diagnosis was confirmed by histopathology. The number of treatment sessions varied from 1 to 8. RESULTS: Response was excellent (>90% reduction in lesion size) in three patients, very good (>75% reduction) in five, good (>50% reduction in lesion size) in five and poor (<50% reduction in lesion size) in two patients. The side effects were hyperpigmentation and scarring. Long-term follow-up over a period of 10 months showed a recurrence rate of 20%. CONCLUSION: We conclude that CO2 laser treatment might be an effective option with long-term safety, minimal discomfort and rapid recovery.

2.
Indian J Dermatol ; 54(4): 334-7, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-20101333

RESUMO

BACKGROUND: Reactive perforating collagenosis (RPC) is one of the rare forms of transepidermal elimination in which genetically altered collagen is extruded from the epidermis. This disease usually starts in early childhood as asymptomatic umbilicated papules on extremities, and the lesions become more conspicuous with age. AIMS: The objective of our study was to determine the clinico-pathological features of RPC and the response to various treatment modalities. METHODS: Ten patients of RPC, belonging to five different families, were studied clinically. Various laboratory investigations were carried out and diagnosis was made by histopathology of the lesions. Patients were given various topical and oral treatments. RESULTS: RPC is familial in most cases without any definite inheritance pattern. It begins in childhood and the lesions are usually recurrent and become profuse and large with age. Systemic diseases have no role in the onset of lesions. CONCLUSION: Oral and topical retinoids in combination with emollients is the best treatment option.

3.
Arterioscler Thromb Vasc Biol ; 22(8): 1329-33, 2002 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-12171796

RESUMO

OBJECTIVE: Paraoxonase (PON1), an esterase physically associated with high density lipoprotein, has been shown to inhibit atherogenic low density lipoprotein and high density lipoprotein oxidation. PON1 activity appears to be primarily under genetic control with some environmental modification and is a predictor of vascular disease. Vitamins C and E, dietary antioxidants, scavenge free-oxygen radical products that may depress PON1 activity. Therefore, we evaluated the relationship between dietary vitamin C and E intake and PON1 activity. METHODS AND RESULTS: The vitamin C and E intakes of male white subjects (n=189) were estimated by using a standardized food frequency survey. With covariates, vitamin C or E intakes were found to be significant positive predictors of PON1 activity for the hydrolysis of paraoxon and diazoxon with the use of linear regression. Smoking and use of statins were independent predictors of PON1 activity. CONCLUSIONS: PON1 activity, which is primarily genotype dependent, varies with antioxidant vitamins, cigarette smoking, and statin drug use. Because PON1 activity is a better predictor of vascular disease than is the currently described genetic variation in PON1, further studies of the environmental influences on PON1 activity and additional PON1 genetic variants are warranted.


Assuntos
Ácido Ascórbico/administração & dosagem , Dieta , Esterases/metabolismo , Vitamina E/administração & dosagem , Idoso , Idoso de 80 Anos ou mais , Arteriosclerose/metabolismo , Arteriosclerose/prevenção & controle , Arildialquilfosfatase , HDL-Colesterol/metabolismo , LDL-Colesterol/metabolismo , Esterases/genética , Genótipo , Humanos , Hipolipemiantes/uso terapêutico , Peroxidação de Lipídeos , Masculino , Pessoa de Meia-Idade , Fumar/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...